From #EASD2026 - SMARTEST indicates that dapagliflozin and metformin offer similar protection against the development of cardiovascular and renal complications for people with early-stage type 2 diabetes.

Full story 👉️ buff.ly/2IrXajI

#CardioSky #MedNews

From #EASD2026 - The ADA and EASD have updated their consensus statement on the management of #T2D in nonpregnant adults in the USA and Europe to include a holistic approach to reduce the risk for the multiple associated conditions in this population.

👉️ buff.ly/dDFThG2

#MedNews

#MedNews: The US primary care shortage is deepening, leaving millions without timely access to care. What will it take to rebuild the workforce?

#MedNews: After the lipoprotein(a)-lowering agent pelacarsen failed to prevent major adverse cardiovascular events in a phase 3 trial, many are wondering what comes next.

From #EURETINA2026 - Two investigational gene therapies for neovascular age-related macular degeneration show favorable safety, maintained visual acuity, and a reduced treatment burden compared with standard anti-VEGF treatment.

Full story 👉️ buff.ly/dMvwh71

#MedNews #EyeSky

From #EURETINA2026 - The bioerodible EYP-1901, an intravitreal insert that delivers vorolanib, has failed to show noninferiority to aflibercept 2 mg in patients with wet AMD despite providing strong anatomic control.

👉️ buff.ly/FiihEys

#MedNews

From #EASD2026 - People with type 2 diabetes have a significantly higher risk for developing cancer than those without the condition.

Full story 👉️ buff.ly/LQRL58n

#T2D #MedNews

From #EURETINA2026 - Vision restoration with the PRIMA subretinal neurostimulation system persists in people with geographic atrophy due to age-related macular degeneration for at least 36 months.

Full story 👉️ buff.ly/dqq8nyF

#MedNews #EyeSky

#MedNews: Unapproved #GLP-1 drugs such as retatrutide and zenagamtide are being sold on the black market, raising concerns about questionable quality and safety issues.

#MedNews: As daily alcohol use declines among younger adults, routine #cannabis use is rising.

What are the risks of more frequent use? Read more:

From #EASD2026 - The long-acting amylin analog petrelintide is well tolerated and can achieve clinically and statistically significant weight loss in people with #obesity compared with placebo.

👉️ buff.ly/BlrCa0G

#MedNews

From #EASD2026 - Orforglipron, an oral non-peptide #GLP1 receptor agonist may be a feasible treatment option for patients with type 2 diabetes who are at increased cardiovascular risk.

Full story 👉️ buff.ly/TRkGkce

#MedNews

#MedNews: A ketogenic diet’s liver health benefits outperformed a Mediterranean diet and a low-fat plant-forward diet in a head-to-head trial of people with metabolically unhealthy obesity.

What are the real-world implications?

#MedNews: Children are using #AI chatbots for advice and emotional support.

Should there be safeguards as the tools become more common?

From #EASD2026 - Mauritius has become the first country to demonstrate a decrease in the prevalence of type 2 diabetes and intermediate hyperglycemia using the oral glucose tolerance test.

Full story 👉️ buff.ly/hZM05mX

#MedNews

From #EASD2026 - The first consensus recommendations for the use of #GLP1 receptor agonists during preconception, pregnancy, and the postnatal period in women with diabetes have been published.

Read the full story 👉️ buff.ly/KEfCaam

#MedNews

#MedNews - Nirsevimab is highly effective in preventing severe respiratory syncytial virus disease requiring emergency department visits, hospitalization, or intensive care unit admission.

👉️ buff.ly/4VREL4W

#IDSky #RSV

#MedNews - A phase 1 study has shown initial evidence that A-319, a bispecific T-cell engager, is well tolerated by patients with systemic lupus erythematosus and efficacious.

👉️ buff.ly/Kg5oa0H

#RheumSky #Lupus

#MedNews - Using optical coherence tomography angiography to measure vessel density may detect glaucoma progression earlier than using OCT to determine structural circumpapillary retinal nerve fiber layer thinning or visual field testing.

👉️ buff.ly/HUP5wQm

#EyeSky

#MedNews - Treatment with the novel antibody–drug conjugate tambotatug pelitecan significantly prolongs the survival of patients with small-cell lung cancer that has progressed after first-line therapy.

👉️ buff.ly/wpqFm8Y

#OncSky #SCLC